RecruitingNCT02670447
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT07003529
This study is looking at care and outcomes for people with Schizophrenia or Hallucinations, Auditory. Some participants may receive Control Group (SCZ+/AH-) instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Schizophrenia
Not Yet RecruitingNCT07266376
This study is comparing Integrative group therapy with Media-workshop control group for people with Mental Disorder or Schizophrenia Diagnosis. Participants receive Integrative group therapy or Media-workshop control group and complete study visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de la Guadeloupe
- Condition
- Schizophrenia
RecruitingNCT07058389
This study is looking at whether a digital support tool can help people with schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT05813457
This study is looking at whether a digital support tool can help people with Psychotic Episode. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT06634641
This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Condition
- Schizophrenia
Not Yet RecruitingNCT07134816
This study is looking at whether a digital support tool can help people with Auditory Hallucinations or Schizophrenia Spectrum. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 15 Years to 45 Years
- Countries
- France
- Sponsor
- University Hospital, Montpellier
- Condition
- Schizophrenia
Not Yet RecruitingNCT06464848
This study is looking at focus on the acquisition of narrative identity in First Episode Psychosis (FEP) and its impact on multidimensional subjective well-being. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 16 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Schizophrenia
Not Yet RecruitingNCT06817980
This study is looking at care and outcomes for people with SCHIZOPHRENIA 1, Borderline Personality Disorder, or Vestibular Syndromes. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT04300946
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT03649581
This study is looking at compare two subforms of psychotic disorders that have been clinically distinguished in the 1970s for people with Schizophrenia. Taking part may give some people access to compare the two groups of schizophrenic patients, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT05550155
This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Caen
- Condition
- Schizophrenia
Active Not RecruitingNCT04867681
This study is looking at whether a mental health workshop can help people with Schizophrenia. Participants take part in a mental health workshop and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Condition
- Schizophrenia
Not Yet RecruitingNCT07055204
This study is looking at whether a digital support tool can help people with Schizophrenia Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Toulouse
- Condition
- Schizophrenia
RecruitingNCT05980949
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07029581
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 84 Years
- Countries
- Bulgaria, Czech Republic, France, Italy, Serbia, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05511363
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Bulgaria, Croatia, Czech Republic, France, Germany, Italy, Serbia, Slovakia, Spain, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT06159673
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 55 Years to 95 Years
- Countries
- Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
Enrolling By InvitationNCT06194799
This study is looking at care and outcomes for people with Alzheimer's Disease Psychosis. Taking part may give some people access to ACP-204, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 95 Years
- Countries
- Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05865652
This observational study is following people with With Ultra High Risk of Psychotic Transition to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 15 Years to 25 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Henri Laborit
- Condition
- Schizophrenia
RecruitingNCT05116514
This study is looking at whether Case management can help people with Psychotic Episode. Participants take part in Case management and complete follow-up assessments.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Schizophrenia
Active Not RecruitingNCT06539611
This observational study is following people with At-risk Mental States to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 15 Years to 30 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Esquirol
- Condition
- Schizophrenia
RecruitingNCT04639388
2 Deletion Syndrome to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 4 Years to 13 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
Not Yet RecruitingNCT07487155
This study is looking at care and outcomes for people with Attention Deficit Disorder With Hyperactivity or Substance Use Disorder. Taking part may give some people access to a mental health workshop, but direct benefit is not guaranteed.
ADHDOtherOver 18 Years
- Countries
- France
- Sponsor
- University Hospital, Brest
- Condition
- ADHD
RecruitingNCT07439276
This observational study is following people with Neurodevelopmental Disorders, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, or Atypical Neurodevelopmental Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
ADHDOtherFrom 8 Years to 16 Years
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Condition
- ADHD